Millipore Acquires NovAseptic AB: Broadens Offering to Biotech and Pharmaceutical Industry
Martin Madaus, Millipore's Chairman, CEO and President, noted: "NovAseptic brings innovative and differentiated products that our biotech and pharmaceutical customers value highly for manufacturing biologics and for monitoring bio-manufacturing processes. There is a great fit strategically and tactically, and we've added exceptional technology and talent to Millipore."
NovAseptic, based in Gothenburg, Sweden, provides a range of innovative solutions for aseptic processing applications in biotech and pharmaceutical manufacturing operations. NovAseptic's products include a unique disposable sampling system (NovaSeptum(R)) and a range of high-performance mixers, valves, and connectors.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.